These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The N-terminal domain of the GluN3A subunit determines the efficacy of glycine-activated NMDA receptors. Mesic I; Madry C; Geider K; Bernhard M; Betz H; Laube B Neuropharmacology; 2016 Jun; 105():133-141. PubMed ID: 26777280 [TBL] [Abstract][Full Text] [Related]
4. Control of aversion by glycine-gated GluN1/GluN3A NMDA receptors in the adult medial habenula. Otsu Y; Darcq E; Pietrajtis K; Mátyás F; Schwartz E; Bessaih T; Abi Gerges S; Rousseau CV; Grand T; Dieudonné S; Paoletti P; Acsády L; Agulhon C; Kieffer BL; Diana MA Science; 2019 Oct; 366(6462):250-254. PubMed ID: 31601771 [TBL] [Abstract][Full Text] [Related]
5. Structure-based discovery of antagonists for GluN3-containing N-methyl-D-aspartate receptors. Kvist T; Greenwood JR; Hansen KB; Traynelis SF; Bräuner-Osborne H Neuropharmacology; 2013 Dec; 75():324-36. PubMed ID: 23973313 [TBL] [Abstract][Full Text] [Related]
7. Lectins modulate the functional properties of GluN1/GluN3-containing NMDA receptors. Hemelikova K; Kolcheva M; Skrenkova K; Kaniakova M; Horak M Neuropharmacology; 2019 Oct; 157():107671. PubMed ID: 31202607 [TBL] [Abstract][Full Text] [Related]
8. Structural features in the glycine-binding sites of the GluN1 and GluN3A subunits regulate the surface delivery of NMDA receptors. Skrenkova K; Hemelikova K; Kolcheva M; Kortus S; Kaniakova M; Krausova B; Horak M Sci Rep; 2019 Aug; 9(1):12303. PubMed ID: 31444392 [TBL] [Abstract][Full Text] [Related]
9. Open-channel blockade is less effective on GluN3B than GluN3A subunit-containing NMDA receptors. McClymont DW; Harris J; Mellor IR Eur J Pharmacol; 2012 Jul; 686(1-3):22-31. PubMed ID: 22564863 [TBL] [Abstract][Full Text] [Related]
10. Allosteric modulation of GluN1/GluN3 NMDA receptors by GluN1-selective competitive antagonists. Rouzbeh N; Rau AR; Benton AJ; Yi F; Anderson CM; Johns MR; Jensen L; Lotti JS; Holley DC; Hansen KB J Gen Physiol; 2023 Jun; 155(6):. PubMed ID: 37078900 [TBL] [Abstract][Full Text] [Related]
11. GluN3A excitatory glycine receptors control adult cortical and amygdalar circuits. Bossi S; Dhanasobhon D; Ellis-Davies GCR; Frontera J; de Brito Van Velze M; Lourenço J; Murillo A; Luján R; Casado M; Perez-Otaño I; Bacci A; Popa D; Paoletti P; Rebola N Neuron; 2022 Aug; 110(15):2438-2454.e8. PubMed ID: 35700736 [TBL] [Abstract][Full Text] [Related]
12. Identification of AICP as a GluN2C-Selective Jessen M; Frederiksen K; Yi F; Clausen RP; Hansen KB; Bräuner-Osborne H; Kilburn P; Damholt A Mol Pharmacol; 2017 Aug; 92(2):151-161. PubMed ID: 28588066 [No Abstract] [Full Text] [Related]
13. The pathogenic S688Y mutation in the ligand-binding domain of the GluN1 subunit regulates the properties of NMDA receptors. Skrenkova K; Song JM; Kortus S; Kolcheva M; Netolicky J; Hemelikova K; Kaniakova M; Krausova BH; Kucera T; Korabecny J; Suh YH; Horak M Sci Rep; 2020 Oct; 10(1):18576. PubMed ID: 33122756 [TBL] [Abstract][Full Text] [Related]
15. Residues in the GluN1 C-terminal domain control kinetics and pharmacology of GluN1/GluN3A N-methyl-d-aspartate receptors. Cummings KA; Belin S; Popescu GK Neuropharmacology; 2017 Jun; 119():40-47. PubMed ID: 28365212 [TBL] [Abstract][Full Text] [Related]
16. Crystal structure and pharmacological characterization of a novel N-methyl-D-aspartate (NMDA) receptor antagonist at the GluN1 glycine binding site. Kvist T; Steffensen TB; Greenwood JR; Mehrzad Tabrizi F; Hansen KB; Gajhede M; Pickering DS; Traynelis SF; Kastrup JS; Bräuner-Osborne H J Biol Chem; 2013 Nov; 288(46):33124-35. PubMed ID: 24072709 [TBL] [Abstract][Full Text] [Related]
17. Specific pathogenic mutations in the M3 domain of the GluN1 subunit regulate the surface delivery and pharmacological sensitivity of NMDA receptors. Kolcheva M; Kortus S; Krausova BH; Barackova P; Misiachna A; Danacikova S; Kaniakova M; Hemelikova K; Hotovec M; Rehakova K; Horak M Neuropharmacology; 2021 May; 189():108528. PubMed ID: 33773999 [TBL] [Abstract][Full Text] [Related]
18. Immuno-Pharmacological Characterization of Presynaptic GluN3A-Containing NMDA Autoreceptors: Relevance to Anti-NMDA Receptor Autoimmune Diseases. Olivero G; Vergassola M; Cisani F; Usai C; Pittaluga A Mol Neurobiol; 2019 Sep; 56(9):6142-6155. PubMed ID: 30734226 [TBL] [Abstract][Full Text] [Related]
19. Structure and function of GluN1-3A NMDA receptor excitatory glycine receptor channel. Michalski K; Furukawa H Sci Adv; 2024 Apr; 10(15):eadl5952. PubMed ID: 38598639 [No Abstract] [Full Text] [Related]
20. Activation-induced structural change in the GluN1/GluN3A excitatory glycine receptor. Balasuriya D; Takahashi H; Srivats S; Edwardson JM Biochem Biophys Res Commun; 2014 Aug; 450(4):1452-7. PubMed ID: 25017909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]